Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

ASCO 2026: Previewing Updates on ADCs and SERDs in mBC

Dr Elizabeth Sakach expects ASCO 2026 data on ADCs and SERDs in metastatic breast cancer will focus on frontline use, sequencing, and socioeconomics.

Conference MDAngle: ASCO 2026 Early Breast Cancer

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in early breast cancer is poised to reshape treatment strategies

Transition From Pediatric to Adult HIV Care: Smooth for All?

Most youth living with HIV transition from pediatric to adult care, but fewer than half maintain timely and ongoing care, a South Carolina study finds.

PRECISE Score Predicts Prostate Cancer Progression

A multicentre validation of the PRECISE scoring system for prostate MRI shows that it effectively predicts disease progression and can reduce unnecessary biopsies for patients on active surveillance.

Insomnia Tied to Greater Symptom Burden in IBS

Insomnia affects a substantial subset of patients with irritable bowel syndrome and is linked to a higher burden of somatic and psychological symptoms and impaired quality of life.

Few Pediatric Cancer Drugs Reach Phase 3 or Approval

Fewer than one out of five anticancer drugs that entered pediatric clinical testing advanced to phase 3 trials, and fewer still earned pediatric regulatory approval, according to recent analysis.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Todays Updates

Antibiotic Stewardship: Five Tips to Reduce Resistance

Clinicians continue prescribing antibiotics unnecessarily despite growing evidence supporting shorter, targeted, and reassessed treatment strategies.

France Expands 2026 Vaccination Rules Amid Resurgence

Nearly 300 experts warn that rising vaccine misinformation is reversing gains — measles and meningococcal infections are resurging while France updates the 2026 schedule.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?

Patients were randomly assigned 1:1 to receive either concurrent radiation dose escalation to the lumpectomy cavity during whole-breast irradiation or sequential boost after whole-breast irradiation.

FDA Expands Use of T-DXd in Early HER2+ Breast Cancer

The agency OK’d trastuzumab deruxtecan for two indications in HER2-positive early-stage breast cancer, covering both the neoadjuvant and adjuvant settings.

Latest News

Dr Elizabeth Sakach expects ASCO 2026 data on ADCs and SERDs in metastatic breast cancer will focus on frontline use, sequencing, and socioeconomics.

Insights from ASCO 2026, including anticipated presentations, key takeaways, and how emerging research in early breast cancer is poised to reshape treatment strategies

Most youth living with HIV transition from pediatric to adult care, but fewer than half maintain timely and ongoing care, a South Carolina study finds.

A multicentre validation of the PRECISE scoring system for prostate MRI shows that it effectively predicts disease progression and can reduce unnecessary biopsies for patients on active surveillance.

Insomnia affects a substantial subset of patients with irritable bowel syndrome and is linked to a higher burden of somatic and psychological symptoms and impaired quality of life.

Fewer than one out of five anticancer drugs that entered pediatric clinical testing advanced to phase 3 trials, and fewer still earned pediatric regulatory approval, according to recent analysis.

News All Time

On the Horizon: Dry Eye in Focus at ARVO 2026

A trio of studies from the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting show the potential of several emerging treatments for dry eye disease.

Two SMA Drugs Move to Routine NHS Funding

NICE has recommended routine NHS access to nusinersen and risdiplam for spinal muscular atrophy, ending time-limited managed access schemes in place since 2019.

Why Epilepsy Transition Matters in Young People

A structured transition from paediatric to adult epilepsy care is linked to improved seizure control between ages of 17 and 20 years in young people with epilepsy.

Neighborhood Factors Affect Timing of Dementia Diagnosis

Black and Hispanic older adults are less likely than White older adults to receive timely diagnosis of dementia, with lower levels of education explaining a substantial proportion of this disparity.

Depression, Not Pain, Drives Costs in Neuromyelitis Optica

In patients with neuromyelitis optica spectrum disorders, depression rather than pain shows the strongest association with healthcare costs.

Early-Onset Colorectal Cancer Risk Factors Identified

Two new studies have identified risk factors that may be associated with the increasing incidence of colorectal cancer among younger Americans.

Streeting Weighs Quitting as NHS Reform Bill Unveiled

Labour turmoil threatens to overshadow NHS modernisation bill as Health Secretary Wes Streeting mulls leadership bid.

At-Home, Mail-In Finger-Stick Test Flags AD Biomarkers

An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in older adults, raising the possibility of large-scale dementia risk screening outside clinical settings.

EU Agrees Draft Deal to Tackle Essential Medicine Shortages

European Union lawmakers and member states reached a provisional deal on Tuesday to strengthen the bloc's supply ⁠of essential medicines by boosting domestic production and...

Free Birth Movement Presents Ethical Quandary: Ethicist

Art Caplan discusses the medical ethics involved in a free birth that went terribly wrong.

Obesity Management After Unsuccessful Dieting

A 45-year-old woman with a BMI of 38 kg/m2 presents with obesity despite lifestyle modifications. This case discussion on obesity highlights management strategies with novel incretin-based therapies.

The Ivermectin Paradox in Oncology

Dr Arturo Loaiza-Bonilla examines the gap between ivermectin’s lab data and clinical reality, offering a guide to debunking ‘miracle cure’ myths while maintaining patient trust.

TikTok and the Squatty Potty: Seeking Help for Constipation

Two studies take different approaches to improving constipation, one examining the influence of TikTok and the other examining the effect of physical positioning.

Peptides Lack Reliable Safety Information, Watchdog Warns

As peptides for wellness surge in popularity, two safety groups warn many users may be injecting unapproved substances with little evidence they are safe or effective.

Adjunctive Antipsychotics for Major Depression Ranked

A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

FDA Expands Vyvgart Approval to All Adults With gMG

The label expansion will include adults with AChR-Ab-negative gMG, making efgartigimod the first and only approved treatment for all serotypes of the rare neuromuscular disease.

Recommended News For You

Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study

Report provides global picture of wide inequalities in care for women's cancers

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Childhood cancer survivors face new health problems later in life, study shows

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Recommended Articles For You

Liquid Biopsies and ctDNA: Transforming Cancer Detection, Monitoring, and Clinical Decisions 

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization 

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides 

Beyond Immunotherapy: Emerging Novel Treatments for Small Cell Lung Cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New protein target discovered for childhood medulloblastomas

2.

Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.

3.

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

4.

PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.

5.

'Ray of hope': New developments in the fight against various cancers.

1.

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision

2.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

3.

Colon Cancer Staging: What You Need to Know

4.

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer 

5.

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Thromboprophylaxis In Medical Settings

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

5.

Efficient Management of First line ALK-rearranged NSCLC - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot